Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
10/10/2023 19:59
Oct 10 (Reuters) - Epigenomics AG ECX1k.DE :
* EQS-ADHOC: EPIGENOMICS AG: CLOSING OF AGREEMENT ON THE
ACQUISITION OF ALMOST ALL ASSETS AND ADJUSTMENT OF GUIDANCE FOR
2023
* EPIGENOMICS AG SAYS EXPECTS 2023 ADJUSTED EBITDA (BEFORE
SHARE-BASED PAYMENT EXPENSES) IN A RANGE OF EUR -4.5 MILLION TO
EUR -5.5 MILLION
Source text for Eikon: ID:nEQ1QKfnka
Further company coverage: ECX1k.DE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns